Page last updated: 2024-10-26

e 4031 and Benign Neoplasms, Brain

e 4031 has been researched along with Benign Neoplasms, Brain in 2 studies

E 4031: class III anti-arrhythmia agent; structure given in UD

Research Excerpts

ExcerptRelevanceReference
"Glioblastoma is the most malignant primary brain tumor, with a median survival of less than 2 years."1.46Administration of Non-Torsadogenic human Ether-à-go-go-Related Gene Inhibitors Is Associated with Better Survival for High hERG-Expressing Glioblastoma Patients. ( Clark, PA; Eliceiri, KW; Kuo, JS; Pointer, KB; Robertson, GA; Salamat, MS, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pointer, KB1
Clark, PA1
Eliceiri, KW1
Salamat, MS1
Robertson, GA1
Kuo, JS1
Faravelli, L1
Arcangeli, A1
Olivotto, M1
Wanke, E1

Other Studies

2 other studies available for e 4031 and Benign Neoplasms, Brain

ArticleYear
Administration of Non-Torsadogenic human Ether-à-go-go-Related Gene Inhibitors Is Associated with Better Survival for High hERG-Expressing Glioblastoma Patients.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Jan-01, Volume: 23, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cel

2017
A HERG-like K+ channel in rat F-11 DRG cell line: pharmacological identification and biophysical characterization.
    The Journal of physiology, 1996, Oct-01, Volume: 496 ( Pt 1)

    Topics: Animals; Anti-Arrhythmia Agents; Benzimidazoles; Brain Neoplasms; Cation Transport Proteins; Cations

1996